Strategic industry investors included Greenleaf Foods, and 301 INC, the venture arm of General Mills.
Image courtesy of Gathered Foods
Gathered Foods, which makes Good Catch plant-based seafood products, announced the closing of an oversubscribed Series B funding round. Strategic industry investors included Greenleaf Foods, and 301 INC, the venture arm of General Mills. The net proceeds from the investment, totaling over $32 million, will be used for the significant expansion in distribution across North America, Europe, and into Asia, as well as the opening of a state-of-the-art manufacturing facility, and new product and food service channel launches in early 2020.
"Consumer demand of trailblazing plant-based alternatives is nearly insatiable, and this trend is led by taste and availability. This next phase for Good Catch is laser focused on meeting consumer desires with culinary applications across all channels," said Chris Kerr, CEO and co-founder of Gathered Foods, in a press release. "This round of investment emphasizes the food industry's recognition of our strategy, our reception by consumers, and anticipation for more innovation to come."
"When we met the Good Catch team, we were immediately captivated with their mission to develop more sustainable plant-based seafood products that taste as delicious as traditional seafood," said John Haugen, managing director of 301 INC, in a press release. "Good Catch stands out as a strong, expandable brand with passionate leadership, and we're excited to partner to grow."
The base of Good Catch products is a proprietary six-legume blend made up of peas, chickpeas, lentils, soy, fava beans, and navy beans, with seaweed and algae extracts creating the umami authentic seafood flavor. The goal is to make Good Catch more widely available. Currently, Good Catch products are in over 4,500 retail outlets across the United States, and will be launching in the United Kingdom in the coming weeks.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.